logo

For the Inventor, By the Inventor

Berlin, Germany

Norbert Schwarz

USPTO Granted Patents = 17

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 164(Granted Patents)


Company Filing History:

goldMedal17 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1980-1992

Loading Chart...
17 patents (USPTO):Explore Patents
1. 5124343 - Carbacyclins, process for the preparation thereof, and use thereof as (1992-06-23),
2. 4983629 - 11-haloprostane derivatives, processes for their preparation and their (1991-01-08),
3. 4870104 - 11-haloprostane derivatives, processes for their preparation and their (1989-09-26),
4. 4789685 - 9-fluoroprostaglandin derivatives, their preparation and use as (1988-12-06),
5. 4708963 - Novel carbacyclins, their preparation and use (1987-11-24),
6. 4567195 - Azaprostacyclins, their preparation and pharmaceutical use (1986-01-28),
7. 4560786 - .DELTA..sup.8,9 -Prostaglandin derivatives, their preparation and use as (1985-12-24),
8. 4489092 - Prostanoic acid derivatives and their preparation (1984-12-18),
9. 4487953 - 9-Bromoprostaglandins, their preparation, and their use as medicaments (1984-12-11),
10. 4454339 - 9-Fluoroprostaglandin derivatives, and use as medicinal agents (1984-06-12),
11. 4446147 - Azaprostacyclins, their preparation and pharmaceutical use (1984-05-01),
12. 4423067 - Carbacyclins, their preparation and use (1983-12-27),
13. 4379927 - Process for the preparation of imidazoleacetic acid derivatives (1983-04-12),
14. 4359467 - Prostanoic acid derivatives and their preparation (1982-11-16),
15. 4284646 - Prostanoic acid derivatives and their preparation (1981-08-18),

Title: Norbert Schwarz: Innovator in Carbacyclins

Introduction

Norbert Schwarz is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of chemistry, particularly in the development of carbacyclins. With a total of 17 patents to his name, Schwarz has established himself as a key figure in innovation.

Latest Patents

One of his latest patents focuses on carbacyclins, detailing a process for their preparation and use. The invention relates to carbacyclins of general Formula I, wherein R₁ is the residue CH₂OH or other specified residues, and R₂ can represent various chemical groups. Additionally, the patent includes 11-haloprostane derivatives, which are crucial for further applications in the field.

Career Highlights

Throughout his career, Norbert Schwarz has been associated with Schering Aktiengesellschaft, a leading pharmaceutical company. His work has not only advanced scientific knowledge but has also contributed to practical applications in medicine and pharmacology.

Collaborations

Schwarz has collaborated with notable colleagues, including Werner Skuballa and Olaf Loge. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Norbert Schwarz's contributions to the field of carbacyclins and his extensive patent portfolio highlight his role as a significant inventor. His work continues to influence advancements in chemistry and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…